0000950170-24-083221.txt : 20240712
0000950170-24-083221.hdr.sgml : 20240712
20240712163004
ACCESSION NUMBER: 0000950170-24-083221
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240710
FILED AS OF DATE: 20240712
DATE AS OF CHANGE: 20240712
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Betz Stephen F.
CENTRAL INDEX KEY: 0001886575
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38583
FILM NUMBER: 241114816
MAIL ADDRESS:
STREET 1: 10222 BARNES CANYON ROAD
STREET 2: BUILDING 2
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Crinetics Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001658247
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 263744114
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10222 BARNES CANYON ROAD, BLDG. #2
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-450-6464
MAIL ADDRESS:
STREET 1: 10222 BARNES CANYON ROAD, BLDG. #2
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
ownership.xml
4
X0508
4
2024-07-10
false
0001658247
Crinetics Pharmaceuticals, Inc.
CRNX
0001886575
Betz Stephen F.
C/O CRINETICS PHARMACEUTICALS, INC.
6055 LUSK BOULEVARD
SAN DIEGO
CA
92121
false
true
false
false
Chief Scientific Officer
true
Common Stock
2024-07-10
4
S
false
3000
48.55
D
78611
D
The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sales price of $48.55 per share. The range of sales prices on the transaction date was $48.63 to $48.46 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.
Includes 968 shares acquired under the Issuer's Employee Stock Purchase Plan.
Marc Wilson, as attorney-in-fact
2024-07-12